✕
Survodutide
🔻
Survodutide
Fat loss
About
History
Charts
Records
GLP-1/glucagon dual agonist (it switches on two metabolism receptors), studied for weight and liver health.
Track Survodutide free
Calculate your exact dose, log every injection, and never miss one. No account needed.
→
Class
GLP-1, fat loss
Forms
Injectable
Typical dose
Titrated weekly
Cycle
Ongoing, titrated
Onset
Appetite drop in 1 to 2 weeks
Tolerance
Nausea early, then eases
Educational summary. See Sources & research below for the underlying studies.
What it is
›
Survodutide is an investigational GLP-1 and glucagon dual agonist studied for weight and liver health.
• Best for: weight loss with a liver-health angle (MASH)
• Edge: glucagon adds a fat-burning push
• Status: investigational, sold for research
How it works
›
It pairs appetite control with a fat-burning signal.
• GLP-1: curbs appetite and slows stomach emptying
• Glucagon: raises energy use and targets liver fat
• Aims at both weight and liver outcomes
Dosing and mixing
›
Reference tiers only. Track the dose you are already taking.
Low
0.5 to 1 mg, once weekly
FOR Easing in, the first weeks
BENEFIT Often picked as a lower-exposure starting tier to assess nausea
Standard
2 to 4 mg, once weekly
FOR Steady fat loss for most people
BENEFIT Commonly picked as the middle range in appetite and weight discussions
High
Up to 6 mg, once weekly
FOR Max range after titration
BENEFIT People report stronger appetite effects here, with more GI side effects
Schedule: One injection per week, same day. Rotate sites.
Beginner ramp: Titrate up slowly over weeks as tolerated.
Mixing (reconstitution)
BAC water is bacteriostatic water, the sterile water you mix in.
A 10 mg vial with 2 mL BAC water is a common starting point.
Calculate my dose →
Ranges are reference only, not a recommendation. See Sources & research below.
How to take it
›
Inject under the skin once a week.
• Same day each week, rotate the spot
• Refrigerate the mixed vial between doses
What to expect
›
Week 1
Appetite begins to drop. Mild nausea as you adjust.
Weeks 2 to 6
Portions shrink and steady loss begins as you titrate.
Months 2 to 6
Main loss window, with possible liver-fat benefits.
Plateaus
Normal, a careful increase usually helps.
Keep in mind
Still investigational, so treat the dosing as approximate.
Side effects
›
Commonly reported
• Nausea, especially early
• Reduced appetite
• Constipation or diarrhea
See a clinician if
• Severe or non-stop vomiting
• Severe abdominal pain
Storage
›
Keep it cold, before and after mixing.
• Powder: refrigerate
• After mixing: fridge, use within about 4 weeks
• Do not freeze, keep out of light
Common stacks
›
• Survodutide + BPC-157: people pair these when GI comfort is a concern during a dose ramp
Sources & research
›
Showed meaningful weight loss and improved liver-fat markers.
Phase 2 trials · Sanyal et al., NEJM 2024 ↗
Status
Investigational, long-term data is still limited.
Sources are provided for education and are not exhaustive. Where a source names a specific trial or journal it is shown above; always confirm with a licensed clinician.
Educational and research information only. Not medical advice. Always confirm dosing and safety with a licensed clinician.
+ Track this
Track
Peptides
Calc
Progress